Back

Prediction of major bleeding in patients receiving DOACs for venous thromboembolism: a prospective cohort study.

31 August 2019 (14:03 - 14:13)
Organised by:
Congress Presentation Part of: Perspectives on anticoagulation across cardiovascular disease Anticoagulants ESC Premium Access ESC Congress 2019

About the speaker

Photo
Doctor Maria Cristina Vedovati

University of Perugia, Perugia (Italy)

7 More presentations in this session

Presentation thumbnail
Use of Non-vitamin K antagonist Oral Anticoagulants in a real-world setting: a community pharmacy-based study.
Mr A. Capiau (Ghent, BE)
Abstract Slides Video
Presentation thumbnail
Potential real-world benefits of low-dose rivaroxaban in Chinese stable cardiovascular patients
Associate Professor B. Yan (Hong Kong, CN)
Abstract Slides Video
Presentation thumbnail
Risk of arterial calcification by conventional vitamin K antagonist treatment
Doctor S. Hasific (Odense, DK)
Abstract Slides Video
Presentation thumbnail
Efficacy and safety of uninterrupted periprocedural edoxaban in patients undergoing catheter ablation for atrial fibrillation: Prospective KYU-RABLE study
Professor N. Takahashi (Oita, JP)
Abstract Slides Video
Presentation thumbnail
Real world persistence with direct oral anticoagulants in anticoagulation naive patients with atrial fibrillation
Doctor G. Denas (Motta Di Livenza, IT)
Abstract Slides Video

Access the full session

Session thumbnail
Perspectives on anticoagulation across cardiovascular disease

The Event

Event poster

ESC Congress 2019

31 August 2019 14:03 CET
You may be interested in
thumbnail
Webinar
Antithrombotic treatment for dual pathway inhibition in cardiovascular disease patients
thumbnail
Congress Presentation
Antithrombotic therapy in diabetes
thumbnail
Congress Presentation
Contemporary thrombosis management -- state of the state

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources